News and Press Releases
CARBOGEN AMCIS introduces SPRINT for early-phase development
A new, phase-appropriate approach designed to accelerate early-phase progression while maintaining scientific rigour 6 May 2026 -- Bubendorf, Switzerland -- CARBOGEN AMCIS has launched SPRINT, a dedicated approach to early-phase...
Category: BioManufacturing, Other, Pharmaceutical
Posted: May 6, 2026
CARBOGEN AMCIS Shanghai Site achieves successful outcome in Unannounced NMPA GMP Inspection
China’s NMPA confirms robust GMP compliance at CARBOGEN AMCIS Shanghai, with no observations identified following a comprehensive unannounced inspection 6 May 2026 -- Bubendorf, Switzerland -- CARBOGEN AMCIS, a Switzerland-based...
Category: BioManufacturing, Clinical Trials, Other, Pharmaceutical
Posted: May 6, 2026
Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035
19 January 2026 -- Bengaluru, India -- Syngene International, a global contract research, development, and manufacturing organization (CRDMO), today announced the extension of its long-standing strategic collaboration with Bristol Myers...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 19, 2026
Biocon Park, SEZ, Bommasandra Industrial Area – Phase-IV, Jigani Link Road, Bangalore, Karnataka – 560 099
ConcertAI and Foundation Medicine Integrate Genomic and Clinical Data to Transform Translational Research and Efficient Drug Development
ConcertAI now offers industry’s most comprehensive clinically-linked dataset to life science organizations Dataset encompasses ConcertAI’s full network of industry partners, representing nearly half a million patients Applications span entire drug...
Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: January 12, 2026
CARBOGEN AMCIS Announces Successful Refinancing and Enhancement of their Syndicated Credit Facilities to Support Continued Growth and Investment
12 November 2025 -- Bubendorf, Switzerland -- CARBOGEN AMCIS, a subsidiary of Dishman Carbogen Amcis, and a global top-tier Contract Development and Manufacturing Organisation (CDMO), today announced the successful refinancing and...
Category: BioManufacturing, Manufacturing and Packing, Other, Pharmaceutical
Posted: November 12, 2025
Ryvu Therapeutics Presents RVU305 (PRMT5i) and ONCO Prime Platform Data at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
RVU305, a potentially best-in-class, brain-permeable MTA-cooperative PRMT5 inhibitor, demonstrates strong and selective antitumor efficacy in MTAP-deleted glioblastoma models, with confirmed brain exposure and a favorable safety profile supporting IND/CTA-enabling studies...
Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: October 27, 2025
R&D Center for Innovative Drugs Leona Henryka Sternbacha 2 30-394 Kraków, Poland
Thermo Fisher Scientific Showcases Enhanced Accelerator Drug Development Capabilities and OpenAI Strategic Collaboration at CPHI Frankfurt 2025
Company highlights its global expertise and new and expanded capabilities to help biopharma and biotech customers solve global health challenges 27 October 2025 -- Frankfurt, Germany -- Thermo Fisher Scientific...
Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: October 27, 2025
Celonic Group and CARBOGEN AMCIS Announce Strategic Alliance to Deliver Fully Integrated ADC Development and Manufacturing Platform
7 October 2025 -- Basel, Switzerland -- CELONIC GROUP, one of the leading “pureplay” Biologics CDMO, and the Carbogen Amcis Group, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API)...
Category: BioManufacturing, Clinical Trials, Manufacturing and Packing, Other, Pharmaceutical
Posted: October 7, 2025
CARBOGEN AMCIS Accelerates Manufacturing Capacity with CHF 25.5 Million Co-Investment at Swiss Sites
4 June 2025 -- Bubendorf, Switzerland -- CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce a strategic co-investment of more...
Category: Logistics, Manufacturing and Packing, Pharmaceutical
Posted: June 4, 2025
CARBOGEN AMCIS Shanghai Site Awarded Drug Manufacturing License from Chinese NMPA
22 April 2025 -- Bubendorf, Switzerland -- CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce that its Shanghai facility has...
Category: BioManufacturing, Manufacturing and Packing, Other, Pharmaceutical
Posted: April 22, 2025
CARBOGEN AMCIS Announces Leadership Transition
3 February 2025 – Bubendorf, Switzerland –Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, has announced the departure of its current CEO, Pascal...
Category:
Posted: February 3, 2025
Swissmedic Inspection Success Highlights Excellence at CARBOGEN AMCIS Vionnaz Site
January 13 2025 – Bubendorf, Switzerland — Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of...
Category: Pharmaceutical
Posted: January 16, 2025
Swissmedic Inspection Success Highlights Excellence at CARBOGEN AMCIS Vionnaz Site
13 January 2025 -- Bubendorf, Switzerland -- Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of a Swissmedic...
Category: BioManufacturing, Manufacturing and Packing, Other, Pharmaceutical
Posted: January 13, 2025
Closed Loop Medicine demonstrates application of digital platform for remote blood pressure and medication monitoring
Study published in JMIR validates the feasibility, use and safety of a digital platform for remote, routine monitoring of blood pressure and medication in hypertension patients Findings support the use...
Category: Biotechnology, Other, Pharmaceutical
Posted: December 17, 2024
Babraham Research Campus Cambridge CB22 3AT United Kingdom
Sapio Sciences Enhances Bioanalysis LIMS and ELN with Advanced Immunogenicity Capabilities
Enhancements support ADA and NAb testing workflows, boosting lab efficiency and regulatory compliance for drug development 15 October 2024 – Maryland, US – Sapio Sciences, the science-aware™ lab informatics platform,...
Category: Biotechnology, Drug Discovery
Posted: October 17, 2024
